FOSL2 and cancer: By analyzing available public GBM datasets from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), we revealed that FOSL2 was highly expressed in mesenchymal GBM (Supplementary Fig. S4A–D), which was consistent with the expression characteristics of RUNX1.